Leukocytoclastic Vasculitis Associated with a New Anticoagulant: Rivaroxaban

Detalles Bibliográficos
Autores principales: Hasbal, Nuri Barış, Baştürk, Taner, Koç, Yener, Sahutoğlu, Tuncay, Bayrakdar Çağlayan, Feyza, Ünsal, Abdülkadir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Galenos Publishing 2017
Materias:
Letters to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5451679/
https://www.ncbi.nlm.nih.gov/pubmed/27796264
http://dx.doi.org/10.4274/tjh.2016.0353
_version_ 1783240221087760384
author Hasbal, Nuri Barış
Baştürk, Taner
Koç, Yener
Sahutoğlu, Tuncay
Bayrakdar Çağlayan, Feyza
Ünsal, Abdülkadir
author_facet Hasbal, Nuri Barış
Baştürk, Taner
Koç, Yener
Sahutoğlu, Tuncay
Bayrakdar Çağlayan, Feyza
Ünsal, Abdülkadir
author_sort Hasbal, Nuri Barış
collection PubMed
description
format Online
Article
Text
id pubmed-5451679
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Galenos Publishing
record_format MEDLINE/PubMed
spelling pubmed-54516792017-06-01 Leukocytoclastic Vasculitis Associated with a New Anticoagulant: Rivaroxaban Hasbal, Nuri Barış Baştürk, Taner Koç, Yener Sahutoğlu, Tuncay Bayrakdar Çağlayan, Feyza Ünsal, Abdülkadir Turk J Haematol Letters to the Editor Galenos Publishing 2017-03 2017-03-01 /pmc/articles/PMC5451679/ /pubmed/27796264 http://dx.doi.org/10.4274/tjh.2016.0353 Text en © Copyright 2017 by Turkish Society of Hematology Turkish Journal of Hematology published by Galenos Publishing House. http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Letters to the Editor
Hasbal, Nuri Barış
Baştürk, Taner
Koç, Yener
Sahutoğlu, Tuncay
Bayrakdar Çağlayan, Feyza
Ünsal, Abdülkadir
Leukocytoclastic Vasculitis Associated with a New Anticoagulant: Rivaroxaban
title Leukocytoclastic Vasculitis Associated with a New Anticoagulant: Rivaroxaban
title_full Leukocytoclastic Vasculitis Associated with a New Anticoagulant: Rivaroxaban
title_fullStr Leukocytoclastic Vasculitis Associated with a New Anticoagulant: Rivaroxaban
title_full_unstemmed Leukocytoclastic Vasculitis Associated with a New Anticoagulant: Rivaroxaban
title_short Leukocytoclastic Vasculitis Associated with a New Anticoagulant: Rivaroxaban
title_sort leukocytoclastic vasculitis associated with a new anticoagulant: rivaroxaban
topic Letters to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5451679/
https://www.ncbi.nlm.nih.gov/pubmed/27796264
http://dx.doi.org/10.4274/tjh.2016.0353
work_keys_str_mv AT hasbalnuribarıs leukocytoclasticvasculitisassociatedwithanewanticoagulantrivaroxaban
AT basturktaner leukocytoclasticvasculitisassociatedwithanewanticoagulantrivaroxaban
AT kocyener leukocytoclasticvasculitisassociatedwithanewanticoagulantrivaroxaban
AT sahutoglutuncay leukocytoclasticvasculitisassociatedwithanewanticoagulantrivaroxaban
AT bayrakdarcaglayanfeyza leukocytoclasticvasculitisassociatedwithanewanticoagulantrivaroxaban
AT unsalabdulkadir leukocytoclasticvasculitisassociatedwithanewanticoagulantrivaroxaban

Ejemplares similares